WOBURN, Mass.--(BUSINESS WIRE)--Frequency Therapeutics, Inc. (Nasdaq: FREQ), a clinical-stage biotechnology company focused on harnessing the body’s innate biology to repair or reverse damage caused ...
Eli Lilly and Co. announced Thursday, Dec. 18 that its experimental daily GLP-1 pill, orforglipron, successfully helped ...
A new phase shifter does not need clean-room facilities for fabrication, so is inexpensive to manufacture. The liquid-metal enabled phase shifting elements have a 'passive' nature, unlike the 'active' ...
Clinical Trials Arena on MSN
Aviceda Therapeutics to advance eye disease drug despite Phase IIb loss
Aviceda Therapeutics’ eye disease drug will advance to Phase III, despite it failing to meet the primary endpoint in a Phase IIb trial. In the SIGLEC study (NCT05839041), AVD-104 showed no statistical ...
Based on successful Phase 3 trial results, that approval is expected to come over the next few months. This new data, announced in a press release from pharma company Eli Lilly and yet to be ...
ZHENJIANG, China--(BUSINESS WIRE)--At 10:16 on January 17, State Grid Zhenjiang Power Supply Company successfully resolved a phase loss fault between Poles 17 and 18 on the 10 kV Antou 292 line of the ...
A new publication from Opto-Electronic Advances, 10.29026/oea.2023.220085 discuss broadband low-loss all-optical phase modulator using gas-filled hollow-core fiber. Optical phase modulators are key ...
Tech Xplore on MSN
Why energy loss peaks at certain speeds in rotor-driven two-phase flows
Researchers have clarified the mechanisms by which energy loss is locally maximized at a certain rotational speed in gas-liquid two-phase flows driven by rotors, providing fundamental insights for ...
Variable frequency drives (VFDs) are used in many industrial applications to improve energy efficiency and provide precise control over electric motors. By adjusting the frequency, voltage and current ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback